
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.56 | 3.66 | 0.10 |
Shares | 96.43 | 96.43 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.05 | 22.45 |
Price to Book | 3.07 | 3.20 |
Price to Sales | 2.10 | 2.19 |
Price to Cash Flow | 6.68 | 12.53 |
Dividend Yield | 0.20 | 0.64 |
5 Years Earnings Growth | 18.65 | 14.34 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 33.02 | 20.27 |
Industrials | 19.42 | 20.26 |
Financial Services | 11.37 | 9.89 |
Technology | 10.17 | 24.04 |
Consumer Cyclical | 7.58 | 11.34 |
Energy | 6.86 | 3.72 |
Consumer Defensive | 5.83 | 4.44 |
Communication Services | 3.72 | 2.19 |
Basic Materials | 1.39 | 3.31 |
Utilities | 0.64 | 1.39 |
Number of long holdings: 135
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Crinetics Pharma | US22663K1079 | 2.06 | 32.39 | -2.99% | |
OneSpaWorld | BSP736841136 | 1.72 | 17.02 | +0.18% | |
GeneDx Holdings Corp Ordinary Shares - Class A | - | 1.62 | - | - | |
Rhythm Pharma | US76243J1051 | 1.60 | 63.76 | +1.25% | |
The Vita Coco Co Inc | - | 1.54 | - | - | |
Stride | US86333M1080 | 1.49 | 140.99 | +1.00% | |
Innodata | US4576422053 | 1.46 | 38.070 | +1.63% | |
QuinStreet | US74874Q1004 | 1.40 | 17.57 | +1.68% | |
Xenon Pharmaceuticals | CA98420N1050 | 1.39 | 37.62 | -1.52% | |
HCI Group Inc | US40416E1038 | 1.37 | 141.92 | -0.70% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Driehaus Emerging Markets Growth | 536.23M | -0.11 | 0.46 | 4.72 | ||
Driehaus International Small Cap Gr | 261.63M | 0.78 | -1.30 | 7.48 | ||
Driehaus Emerging Markets Small Cap | 117.2M | -3.69 | 1.02 | 4.88 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review